Research Examines Options for Those With Early-stage Breast Cancer

    loading  Checking for direct PDF access through Ovid

Abstract

Results of a large-scale study indicated that 70% of women with a common type of breast cancer do not experience a benefit from chemotherapy. Data suggest that for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, axillary lymph node-negative breast cancer, post-surgery combination chemotherapy and hormone therapy treatment provides no additional benefit over hormone therapy on its own.

Related Topics

    loading  Loading Related Articles